EN – Grant of share options
Cryo-Save Group N.V. (AIM/Euronext: CRYO, ‘Cryo-Save’ or ‘the Group’), Europe’s leading stem cell bank, announces that on 28 April 2010 the Group granted options to subscribe for ordinary shares in the Company under the Cryo-Save Group 2009 Share Option Scheme.
The Company granted 20,000 options to Arnoud van Tulder, Chief Financial Officer, and 34,000 options to certain other employees of the Group all at an exercise price of €5.81 per share, being the price equal to the arithmetic average of the closing mid-market price over the five dealing days prior to the date of the grant. All of these options are exercisable at any time from 29 April 2013 until 29 April 2020. The Company now has a total of 204,000 options over ordinary shares outstanding.
+ 31 (0)575 548998
Marc Waeterschoot, Chief Executive Officer
Arnoud van Tulder, Chief Financial Officer
Daniel Stewart & Company plc
+ 44 (0) 20 7776 6550
Simon Leathers/Emma Earl
College Hill (UK)
+ 44 (0) 20 7457 2020
Adrian Duffield/Rozi Morris
SPJ Financiële Communicatie Amstelveen (NL)
+ 31 (0)20 647 8181
Kees Jongsma/Léon Melens